quantit
structureact
relationship
qsar
approach
classif
use
predict
compound
activeinact
rel
overal
biolog
activ
antitumor
antibiot
activ
use
data
set
compound
pubchem
empir
cdk
descriptor
semiempir
quantumchem
descriptor
data
set
activ
pharmaceut
ingredi
addit
use
extern
valid
best
model
best
classif
model
antibiot
antitumor
activ
use
screen
data
set
marin
microbi
natur
product
antimarin
four
lead
compound
antibiot
antitumor
drug
design
propos
respect
present
work
enabl
present
new
set
possibl
lead
like
bioactiv
compound
corrobor
result
previou
investig
side
shown
use
quantumchem
descriptor
discrimin
biolog
activ
inact
compound
none
compound
suggest
approach
assign
nonantibiot
nonantitumor
activ
antimarin
databas
almost
late
report
activ
literatur
natur
product
np
synthet
product
inspir
np
singl
product
sourc
lead
develop
drug
fact
half
approv
drug
base
np
detect
antibiot
properti
penicillin
fleme
golden
age
antibiot
almost
group
import
antibacteri
antibiot
eg
tetracyclin
cephalosporin
aminoglycosid
macrolid
discov
late
centuri
promis
unpreced
structur
divers
potent
biolog
activ
microbi
secondari
metabolit
remain
power
forc
drive
pharmaceut
discoveri
microb
prolif
sourc
bioactiv
metabolit
rate
compar
overal
rate
np
sourc
furthermor
bacteria
except
sourc
small
molecul
chemic
divers
although
terrestri
bacteria
studi
past
grow
interest
distribut
ecolog
role
marin
environ
observ
ocean
highli
complex
microbiolog
environ
typic
microbi
abund
per
ml
seawat
oceanbottom
sediment
respect
instanc
rare
complex
dens
function
pharmacophor
salinosporamid
trade
name
marizomib
seawateroblig
marin
actinomycet
bacteria
salinispora
tropica
head
phase
ii
clinic
trial
cancer
may
clinic
candid
due
demis
nereu
pharmaceut
late
marin
organ
import
sourc
structur
divers
biolog
activ
secondari
metabolit
new
branch
np
chemistri
fulli
establishedmarin
natur
product
mnp
current
success
rate
discoveri
marin
world
seven
clinic
approv
drug
four
anticanc
one
antivir
one
pain
control
one
hypertriglyceridemia
discov
molecular
entiti
eg
one
drug
per
np
describ
approxim
better
industri
averag
one
test
compound
current
facil
highthroughput
screen
avail
academ
lab
well
drug
pharmaceut
compani
cost
random
screen
larg
collect
compound
nevertheless
prohibit
thu
make
sens
use
chemoinformat
approach
virtual
screen
probabl
activ
compound
although
last
year
comput
approach
appli
silico
screen
np
field
significantli
improv
model
data
larg
databas
contain
inform
rel
biolog
activ
becom
avail
scientif
commun
antimarin
good
exampl
power
databas
contain
approxim
compound
marin
macroorgan
marin
terrestri
microorgan
databas
fact
result
fusion
antibas
databas
terrestri
marin
microbi
np
marinlit
databas
mnp
literatur
therefor
besid
mnp
refer
np
deriv
microbi
sourc
microbi
natur
product
mbnp
account
terrestri
origin
last
year
quantumchem
descriptor
use
success
great
varieti
sprqspr
sarqsar
applic
predict
chemic
reactiv
physicochem
properti
partit
coeffici
chromatograph
retent
index
biolog
activ
context
qsar
studi
quantumchem
descriptor
eg
net
atom
charg
homo
lumo
energi
hard
chemic
potenti
electrophil
index
shown
use
estim
variou
biolog
activ
exampl
studi
relat
estim
toxic
mutagen
carcinogen
well
studi
mechan
action
use
descriptor
also
demonstr
estim
studi
antioxid
antitumor
antibacteri
activ
theoret
studi
electron
properti
chemic
reactiv
quercetin
catechin
epicatechin
well
report
studi
electrophil
index
relat
abil
np
isoprekinamycin
kinamycin
lomaiviticin
act
antitumor
antibacteri
agent
studi
antileukaem
activ
phenol
suppress
breast
cancer
chemic
modul
vulner
zinc
finger
estrogen
receptor
quantumchem
descriptor
also
use
analysi
relat
structur
properti
antitumor
activ
synthet
chalcon
antimicrobi
activ
nphenylbenzamid
deriv
antiparasit
activ
nifurtimox
analogu
also
correl
electrophil
index
group
combin
quantum
chemic
empir
descriptor
use
past
establish
qsrr
model
estim
mayr
electrophil
great
success
present
studi
focus
applic
machin
learn
ml
techniqu
exploit
leadlik
molecul
en
rout
antitumor
antibiot
drug
mnp
mbnp
extract
antimarin
databas
antimarin
set
model
develop
use
activ
nonact
compound
pubchem
databas
stateoftheart
ml
algorithm
support
vector
machin
svm
random
forest
rf
classif
tree
ct
compar
predict
two
class
ie
activ
nonact
compound
follow
classif
task
overal
biolog
activ
antitumor
activ
antibiot
activ
task
three
model
built
use
cdk
descriptor
eight
semiempir
quantumchem
descriptor
calcul
method
descriptor
final
use
simultan
cdk
descriptor
descriptor
use
intern
crossvalid
outofbag
estim
train
set
extern
valid
two
extern
data
set
pubchem
test
set
compris
compound
test
set
ii
compris
activ
pharmaceut
ingredi
test
qsar
model
valid
addit
test
set
antimarin
set
extract
antimarin
databas
use
main
purpos
extern
model
valid
result
obtain
three
approach
compar
recent
publish
work
use
cdk
descriptor
result
intern
valid
tenfold
crossvalid
svm
outofbag
estim
rf
train
set
extern
valid
test
set
task
ie
overal
biolog
activ
antitumor
antibiot
activ
present
tabl
note
tenfold
crossvalid
b
outofbag
c
ratio
true
posit
sum
true
posit
fals
neg
ratio
true
neg
sum
true
neg
fals
posit
e
squar
root
product
sensit
specif
f
qsar
model
built
use
cdk
descriptor
g
qsar
model
built
use
quantummechan
descriptor
calcul
semiempir
method
addit
test
set
antimarin
set
extract
antimarin
databas
also
use
main
purpos
extern
model
valid
antimarin
data
set
screen
develop
model
find
leadlik
molecul
en
rout
antitumor
antibiot
drug
inde
core
present
moreov
inclus
quantumchem
descriptor
long
use
qsar
studi
biochemistri
allow
opportun
evalu
import
model
overal
biolog
antitumor
antibiot
activ
best
model
accomplish
task
rf
show
better
perform
compar
singl
ct
svm
predict
overal
biolog
antitumor
antibiot
activ
test
set
use
cdk
descriptor
descriptor
take
account
valu
gmean
tabl
predict
obtain
model
use
simultan
cdk
descriptor
slightli
better
use
cdk
descriptor
tabl
howev
task
perform
model
built
descriptor
wors
obtain
use
cdk
descriptor
expect
predict
power
take
account
valu
gmean
test
set
ct
lower
obtain
two
ml
techniqu
almost
activ
model
differ
approach
ie
cdk
model
howev
ct
advantag
establish
simpl
rule
provid
insight
properti
drug
profil
given
biolog
activ
moreov
best
rf
model
valid
use
test
set
ii
compris
activ
pharmaceut
ingredi
api
also
extract
pubchem
result
shown
tabl
although
predict
obtain
test
set
ii
use
cdk
descriptor
gener
better
obtain
use
cdk
descriptor
appear
import
descriptor
greater
data
set
test
set
result
discuss
lead
topic
present
follow
section
note
qsar
model
built
use
cdk
descriptor
b
qsar
model
built
use
quantummechan
descriptor
calcul
semiempir
method
c
ratio
true
posit
sum
true
posit
fals
neg
ratio
true
neg
sum
true
neg
fals
posit
e
squar
root
product
sensit
specif
f
applic
one
mostwid
use
multivari
exploratori
techniqu
princip
compon
analysi
pca
abl
detect
similar
among
data
set
compound
provid
statist
reliabl
criterion
classifi
compound
upon
differ
physicochem
properti
pattern
differ
biolog
activ
obtain
gener
impress
data
set
use
model
ie
train
test
set
test
set
ii
pubchem
antimarin
set
pca
model
deriv
cdk
descriptor
describ
rang
electron
steric
geometr
quantum
properti
compound
first
two
compon
respect
account
varianc
descriptor
matrix
shown
figur
result
obtain
pca
score
plot
figur
show
clearli
defin
separ
exist
four
data
set
base
upon
major
sourc
variat
within
electron
steric
geometr
quantum
properti
profil
train
set
test
set
antimarin
set
test
se
ii
figur
pca
score
plot
deriv
cdk
descriptor
versu
bottom
plot
amplif
cluster
highlight
moreov
approxim
compound
four
data
set
well
cluster
togeth
cluster
highlight
figur
therefor
predict
test
set
may
consid
reliabl
sinc
compound
fall
within
chemicalspac
domain
defin
train
set
compound
use
build
qsar
model
overal
biolog
activ
model
data
imbalanc
concern
activ
nonact
class
henc
caus
problem
ct
method
abl
balanc
two
class
done
two
method
ie
adjust
weight
class
expect
overal
ct
biolog
model
use
cdk
approach
show
poor
predict
accuracya
gmean
test
set
respect
tabl
howev
appear
improv
predict
power
ct
model
inclus
descriptor
sinc
ct
overal
biolog
model
use
cdk
descriptor
show
lower
predict
accuraci
gmean
test
set
overal
biolog
activ
model
intend
improv
precis
leadlik
profil
compens
lack
bioactiv
record
compound
extract
antimarin
databas
done
previou
work
well
compar
select
lead
bioactiv
compound
propos
two
approach
animarin
databas
almost
databas
molecul
test
activ
chosen
research
grant
program
almost
certainli
mani
bioactiv
molecul
lack
activ
record
probabl
compound
classifi
nonact
one
given
biolog
activ
never
test
biolog
assay
therefor
would
expect
difficulti
model
actual
fals
posit
fp
antimarin
set
fact
obtain
larg
number
fp
antimarin
set
shown
low
specif
valu
obtain
best
model
rf
use
compar
high
specif
valu
obtain
test
set
tabl
analysi
result
obtain
best
rf
model
shown
fp
antimarin
set
test
set
respect
fp
obtain
averag
probabl
activ
avgprobact
best
rf
model
fp
avgprobact
fp
avgprobact
antimarin
set
test
set
respect
mani
author
tri
ration
druglik
leadlik
natur
compound
waldmann
et
al
suggest
statist
analysi
structur
classif
np
leadlik
molecul
must
scaffold
two
three
four
ring
van
der
waal
volum
must
match
lower
end
major
protein
caviti
ie
van
der
waal
volum
inde
recent
report
analysi
activ
nonact
profil
van
der
waal
volum
train
set
test
set
pubchem
antimarin
set
antimarin
reveal
correl
activ
compound
compound
van
der
waal
volum
antimarin
set
compound
specif
compound
ie
approxim
activ
compar
approxim
activ
compound
test
set
compound
pubchem
specif
moreov
specif
compound
predict
true
posit
tp
fp
avgprobact
respect
use
best
rf
model
antimarin
set
test
set
ii
approxim
api
specif
predict
activ
best
rf
model
energi
highest
occupi
molecular
orbit
first
second
descriptor
select
build
overal
biolog
activ
classif
tree
model
use
descriptor
respect
see
tabl
furthermor
import
descriptor
meandecreasegini
measur
rf
model
well
select
build
svm
model
see
tabl
use
first
rule
overal
biolog
activ
classif
tree
ev
activ
compound
possibl
correctli
discrimin
activ
compound
correspond
train
set
compound
correspond
test
set
compound
correspond
test
set
ii
known
energi
lowest
unoccupi
molecular
orbit
molecul
play
import
role
intermolecular
interact
interact
drug
receptor
vice
versa
increas
decreas
drug
molecul
lead
enhanc
stabil
interact
consequ
bind
receptor
remark
perform
descriptor
discrimin
leadlik
druglik
compound
never
report
howev
report
could
use
predict
potenc
blocker
famotidin
ranitidin
nizatidin
author
found
posit
correl
potenc
drug
seen
tabl
perform
rf
model
even
better
rf
model
test
set
ii
gmean
respect
fourteen
mnp
mbnp
scheme
list
probabl
activ
probact
greater
equal
use
best
rf
activ
model
test
set
activ
compound
predict
probact
greater
equal
use
best
rf
activ
model
propos
mnp
mbnp
lead
bioactiv
compound
consid
misclassifi
nonact
compound
antimarin
databas
addit
eleven
fourteen
propos
lead
bioactiv
compound
also
propos
us
use
cdk
rf
model
three
fp
propos
lead
antibiot
compound
rf
antibiot
model
use
cdk
descriptor
predict
activ
probact
greater
equal
previous
cdk
rf
overal
biolog
activ
model
interestingli
one
compound
aklavinon
glycosid
id
fourteen
propos
mnp
mbnp
lead
bioactiv
compound
valu
lower
ev
lead
bioactiv
mnp
mbnp
antimarin
databas
recent
report
activ
literatur
instanc
deriv
arbekacin
id
see
scheme
identifi
resist
mani
inactiv
enzym
retain
intrins
antibiot
activ
unsubstitut
molecul
suscept
strain
bleomycin
current
known
complex
relat
glycopeptid
antibiot
produc
bacterium
streptomyc
verticillu
clinic
use
treatment
certain
cancer
type
far
know
specif
bioactiv
bleomycin
deriv
id
antimarin
databas
never
record
although
n
propyl
bleomycin
employ
clinic
combin
number
agent
treatment
sever
type
tumor
eg
notabl
squamou
cell
carcinoma
malign
lymphoma
best
antitumor
model
rf
model
obtain
larg
number
fp
well
fn
antimarin
set
reveal
low
sensit
specif
valu
respect
valu
could
compar
sensit
specif
valu
obtain
test
set
respect
tabl
analysi
predict
obtain
antimarin
set
shown
tp
averag
probabl
antitumor
avgprobantitumor
compar
avgprobantitumor
obtain
fp
predict
opinion
fp
misclassif
antitumor
model
instead
high
probabl
antitumor
probantitumor
leadlik
antitumor
mnp
mbnp
misclassifi
nonantitumor
compound
antimarin
databas
although
obtain
high
sensit
valu
extern
test
set
ii
also
achiev
low
specif
valu
test
set
ii
use
biolog
activ
report
pharmacolog
classif
api
howev
data
set
pubchem
report
averag
valu
test
bioassay
averag
valu
activ
bioassay
therefor
obtain
tp
fp
probantitumor
greater
equal
analysi
eleven
fp
higher
probantitumor
ie
avgprobantitumor
shown
least
one
posit
bioassay
cancer
avail
supplementari
materi
tabl
conclus
also
support
low
percentag
misclassif
fp
obtain
test
set
compound
probantitumor
greater
equal
use
best
rf
antitumor
model
scheme
list
fp
probantitumor
greater
equal
use
best
rf
antitumor
model
two
four
propos
lead
antitumor
compound
also
propos
us
use
cdk
rf
model
recent
publish
work
two
fp
similarli
predict
antitumor
probantitumor
greater
equal
cdk
rf
antitumor
activ
model
moreov
eight
id
sixteen
propos
lead
antitumor
mnp
mbnp
antimarin
databas
previou
work
present
current
studi
five
lead
antitumor
compound
id
recent
highlight
studi
also
predict
antitumor
compound
best
rf
model
probantitumor
respect
howev
antitumor
activ
report
recent
almost
fp
obtain
name
see
scheme
phenazin
deriv
id
lightactiv
tumor
cytotox
compound
oxim
deriv
id
sever
nci
human
tumor
cell
nitrosohydrazon
deriv
id
enhanc
etoposideinduc
cell
death
human
glioma
cell
synergist
effect
antitumor
drug
act
inhibitor
acetylcoenzym
synthetas
antifung
bromin
phenylpyrrol
deriv
id
scheme
relat
chlorin
pyrrolnitrin
antibiot
antifung
mnp
test
set
cid
see
scheme
recent
report
activ
screen
potenti
antitumor
activ
best
antibiot
model
rf
model
yield
larg
number
fp
well
fn
antimarin
set
shown
low
sensit
specif
valu
obtain
respect
valu
could
compar
sensit
specif
valu
obtain
respect
test
set
tabl
analysi
predict
obtain
antimarin
set
shown
tp
averag
probabl
antibiot
avgprobantibiot
compar
avgprobantibiot
obtain
fp
predict
opinion
fp
misclassif
antibiot
model
instead
high
probabl
antibiot
probantibiot
may
leadlik
antibiot
mnp
mbnp
misclassifi
nonantibiot
compound
antimarin
databas
done
antitumor
biolog
overal
model
propos
fp
probantibiot
greater
equal
antimarin
set
lead
antibiot
compound
tabl
given
supplementari
materi
analysi
predict
obtain
antimarin
set
shown
seven
fp
probantibiot
greater
equal
seven
fp
four
fp
id
alreadi
analyz
overal
biolog
model
scheme
three
fp
id
report
us
leadlik
antibiot
compound
probantibiot
greater
equal
addit
twenti
one
twenti
five
propos
lead
antibiot
compound
well
propos
us
use
cdk
rf
model
four
fp
id
classifi
antibiot
compound
rf
antibiot
model
use
cdk
descriptor
predict
antibiot
probact
greater
equal
cdk
rf
overal
biolog
activ
model
leadlik
antibiot
mnp
mbnp
seven
id
alreadi
analyz
overal
biolog
model
scheme
scheme
illustr
fp
probantibiot
greater
equal
yet
report
work
recent
describ
team
sever
cephalosporin
analog
appear
antimarin
databas
without
activ
record
classifi
activ
overal
activ
antibiot
model
indic
cephalosporin
core
structur
appear
relev
antibiot
activ
structur
could
seen
scheme
id
scheme
id
howev
surpris
outcom
sinc
penicillin
cephalosporin
well
known
antibiot
drug
earliest
antibiot
discov
penicillin
analog
also
classifi
fp
id
scheme
among
relev
type
antibiot
classifi
fp
model
aminoglycosid
id
anthracyclin
antibiot
id
two
uniqu
cyclic
peptid
incorpor
unusu
acid
acid
acid
acid
id
also
classifi
antibiot
far
know
antibiot
activ
compound
never
record
report
shown
immunosuppress
activ
product
inhibit
assay
three
larg
macrocycl
lacton
lactam
ring
deriv
id
also
classifi
antibiot
although
lack
report
antibiot
activ
deriv
antibiot
activ
macrolid
class
compound
larg
macrocycl
lacton
ring
well
known
set
descriptor
select
cf
filter
develop
model
present
tabl
model
built
use
cpsa
charg
partial
surfac
area
topolog
constitut
molecular
descriptor
semiempir
quantumchem
descriptor
topopsatopolog
polar
surfac
areadescriptor
select
use
model
model
built
use
three
approach
one
cdk
descriptor
semiempir
quantumchem
descriptor
calcul
method
cdk
descriptor
select
import
descriptor
obtain
three
approach
compar
previou
studi
use
cdk
descriptor
ten
relev
descriptor
found
rf
algorithm
use
build
rf
model
also
includ
almost
case
differ
type
descriptor
mention
meandecreaseaccuraci
paramet
mean
decreas
accuraci
import
consid
reliabl
meandecreasegini
paramet
mean
decreas
gini
coeffici
take
account
meandecreaseaccuraci
measur
best
rf
model
predict
overal
biolog
activ
antitumor
antibiot
activ
possibl
correl
activ
type
descriptor
select
instanc
overal
biolog
activ
appear
relat
electron
molecular
quantum
descriptor
cpsa
bcut
whim
descriptor
well
seem
main
role
model
overal
activ
bcut
descriptor
encod
connect
inform
atom
properti
molecul
whim
descriptor
weight
holist
invari
molecular
descriptor
built
way
captur
relev
molecular
inform
respect
molecular
size
shape
symmetri
atom
distribut
nevertheless
antitumor
activ
appear
larg
relat
topolog
descriptor
addit
molecular
distanc
edg
descriptor
mde
evalu
molecular
distanc
edg
descriptor
carbon
nitrogen
oxygen
atom
seem
import
type
descriptor
model
antitumor
activ
molecular
distanc
edg
primari
secondari
oxygen
atom
khssssch
fragment
count
descriptor
encod
presenc
tertiari
carbon
group
three
singl
bond
descriptor
select
machin
learn
techniqu
ie
cf
filter
svm
two
measur
rf
ct
use
approach
second
import
descriptor
meandecreaseaccuraci
meandecreasegini
paramet
best
rf
model
well
first
descriptor
select
build
antitumor
classif
tree
use
first
rule
antitumor
tree
antitumor
compound
nonantitumor
compound
possibl
correctli
discrimin
antitumornonantitumor
compound
correspond
train
set
compound
correspond
test
set
result
even
impress
rule
appliedfrom
antitumor
compound
correctli
classifi
train
set
test
set
leadlik
antitumor
mnp
mbnp
alreadi
propos
classifi
antitumor
rule
remark
perform
descriptor
discrimin
antitumor
nonantitumor
compound
report
us
descriptor
known
codifi
molecular
size
take
account
oxygen
atom
also
character
polar
inspect
compound
belong
train
set
reveal
descriptor
provid
indic
presenc
oxygencontain
group
glycosyl
amid
lactam
ester
lacton
togeth
hydroxyl
carboxyl
acid
ether
function
group
antibiot
activ
seem
relat
mainli
topolog
constitut
descriptor
four
descriptor
select
machin
learn
techniqueson
electron
topopsa
two
topolog
distanc
edg
secondari
carbon
atom
one
constitut
khssssch
topopsa
import
descriptor
meandecreasegini
paramet
rf
model
well
first
descriptor
select
build
antibiot
tree
use
first
rule
antibiot
tree
topopsa
antibiot
compound
topopsa
nonantibiot
compound
possibl
correctli
discrimin
antibioticnonantibiot
compound
train
set
test
set
respect
subsequ
topopsa
descriptor
present
similar
result
antibiot
nonantibiot
class
differ
antitumor
ct
model
descriptor
show
impress
discrimin
abil
rel
antitumor
compound
global
compound
correctli
classifi
rule
antibiot
compound
nonantibiot
compound
correctli
classifi
train
set
similar
result
obtain
test
set
two
mbnp
leadlik
antibiot
mnp
mbnp
alreadi
propos
classifi
nonantibiot
id
rule
remark
descriptor
discrimin
antibiot
nonantibiot
compound
accord
previou
studi
train
test
set
extract
pubchem
databas
search
differ
type
biolog
activ
avail
databas
eg
antitumor
antibiot
antimicrobi
antifung
antimalari
antihiv
retriev
chemic
structur
save
smile
string
train
test
set
use
build
qsar
model
classif
previou
work
data
set
randomli
partit
train
test
set
except
compound
produc
error
process
calcul
semiempir
quantumchem
descriptor
train
set
test
set
consist
antitumor
antibiot
antifung
antimalari
one
antihiv
antimicrobi
cytotox
nonact
compound
note
compound
one
bioactiv
record
nonact
compound
select
basi
screen
least
one
biolog
activ
train
set
consist
compound
test
set
compound
dataset
use
develop
extern
valid
qsar
classif
model
respect
set
antimarin
set
mnp
mbnp
extract
antimarin
databas
set
use
test
model
exploit
leadlik
molecul
mnp
mbnp
addit
test
set
test
set
ii
also
extract
pubchem
contain
api
follow
pharmacolog
classif
antitumor
antibiot
eight
antihiv
antiinflamatori
antifung
six
antivir
six
insecticid
nine
antimalari
seven
antiulc
chemic
structur
mnp
mbnp
download
mdl
sdf
format
differ
set
assembl
duplic
remov
avoid
overlap
two
databas
although
chiral
taken
account
racem
compound
case
stereochemistri
indic
consid
one
possibl
stereoisom
smile
string
four
differ
data
set
natur
sourc
compound
antimarin
set
correspond
experiment
predict
activ
avail
supplementari
materi
tabl
jchem
standard
tool
version
chemaxon
ltd
budapest
hungari
use
standard
molecular
structur
normal
tautomer
group
remov
small
fragment
corina
version
molecular
network
gmbh
erlangen
germani
use
gener
structur
compound
structur
empir
molecular
descriptor
includ
electron
topolog
geometr
constitut
hybrid
bcut
whim
descriptor
calcul
use
cdk
descriptor
calcul
calcul
semiempir
quantum
chemic
descriptor
perform
semiautomat
way
use
follow
step
gener
stabl
conform
use
leconform
method
jchem
cxcalc
tool
chemaxon
ltd
b
optim
geometri
use
semiempir
method
c
calcul
harmon
vibrat
frequenc
determin
optim
geometri
minima
potenti
energi
surfac
real
frequenc
theori
level
semiempir
quantum
chemic
descriptor
extract
directli
mopac
output
energi
highest
occupi
molecular
orbit
energi
lowest
unoccupi
molecular
orbit
two
orbit
energi
follow
descriptor
calcul
hard
chemic
potenti
mulliken
electroneg
parr
popl
absolut
hard
schuurmann
mo
shift
alpha
electrophil
index
defin
parr
et
al
quantumchem
descriptor
measur
electronvolt
ev
first
step
select
best
set
descriptor
model
differ
activ
remov
constant
descriptor
ie
descriptor
present
valu
compound
data
set
usual
zero
multilinear
regress
mlr
built
weka
select
descriptor
method
use
train
set
give
origin
set
descriptor
next
step
select
best
set
descriptor
model
activ
consist
applic
correlationbas
featur
subset
select
algorithm
algorithm
evalu
use
individu
descriptor
predict
given
activ
also
level
intercorrel
among
descriptor
implement
weka
select
perform
use
attributeselectedclassifi
routin
weka
cfssubsetev
option
descriptor
evalu
bestfirst
linearforwardselect
greedystepwis
option
search
method
within
tenfold
crossvalid
procedur
k
nearest
neighbor
knn
algorithm
ml
techniqu
knn
algorithm
predict
activ
compound
major
vote
k
similar
compound
train
set
knn
model
implement
weka
softwar
use
paramet
k
similar
neighbour
queri
compound
euclidean
distanc
measur
similar
contribut
neighbour
weight
invers
distanc
ct
grown
use
rpart
librari
default
paramet
r
program
version
classif
tree
sequenti
construct
partit
compound
parent
node
two
child
node
node
produc
logic
rule
defin
singl
descriptor
object
certain
descriptor
valu
fall
one
two
child
node
object
fall
child
node
predict
compound
reach
given
termin
node
obtain
major
vote
object
train
set
reach
termin
node
ct
model
built
three
approach
one
use
cdk
descriptor
use
eight
semiempir
quantumchem
descriptor
calcul
method
descriptor
final
use
cdk
descriptor
descriptor
rf
ensembl
unprun
classif
tree
creat
use
bootstrap
sampl
train
data
set
best
split
node
defin
among
randomli
select
subset
descriptor
predict
made
major
vote
classif
tree
forest
perform
intern
assess
predict
error
object
left
bootstrap
procedur
intern
crossvalid
oob
estim
addit
method
quantifi
import
descriptor
increas
misclassif
occur
valu
descriptor
randomli
permut
correl
mean
decreas
accuraci
paramet
decreas
node
impur
everi
time
descriptor
use
split
correl
mean
decreas
gini
coeffici
paramet
rf
also
assign
probabl
everi
predict
basi
number
vote
obtain
predict
class
measur
similar
two
object
calcul
number
tree
ensembl
classifi
two
object
termin
node
rf
grown
r
program
version
use
random
forest
librari
rf
model
built
tree
three
approach
one
use
cdk
descriptor
use
semiempir
quantumchem
descriptor
calcul
method
descriptor
final
use
cdk
descriptor
descriptor
result
natur
twoclass
imbal
overal
activ
model
problem
allevi
set
class
weight
svm
map
data
hyperspac
nonlinear
map
boundari
hyperplan
separ
two
class
compound
space
boundari
posit
use
exampl
train
set
known
support
vector
nonlinear
data
kernel
function
use
transform
hyperspac
class
becom
linearli
separ
present
work
svm
model
establish
weka
program
use
libsvm
packag
type
svm
set
csvmclassif
kernel
function
radial
basi
function
paramet
c
csvmclassif
optim
rang
default
paramet
kernel
function
use
descriptor
select
cf
procedur
normal
use
develop
classif
model
activ
nonact
class
overal
activ
model
set
weight
respect
work
compar
predict
power
qsar
classif
model
base
quantumchem
descriptor
comput
method
empir
descriptor
cdk
result
suggest
implement
computeraid
approach
use
quantumchem
descriptor
could
use
predict
bioactiv
new
exist
np
without
bioactiv
record
way
identifi
propos
lead
compound
en
rout
specifi
activ
improv
perform
compar
qsar
model
built
cdk
descriptor
result
applic
approach
reduct
great
extent
number
compound
use
real
screen
hand
allow
confirm
previou
previs
obtain
result
present
virtual
screen
possibl
lead
compound
en
rout
antitumor
antibiot
drug
also
extern
support
public
literatur
activ
compound
compound
propos
initi
classifi
antimarin
databas
nonact
compound
without
activ
record
remark
perform
quantumchem
descriptor
discrimin
larg
scale
data
set
leadlik
druglik
compound
never
report
evalu
discrimin
power
quantum
descriptor
calcul
quantum
level
larg
set
bioactiv
molecul
could
interest
approach
futur
work
supplementari
materi
access
http
marvin
molecular
network
gmbh
access
corina
author
thank
w
fenic
access
databas
spg
postdoctor
research
scripp
institut
oceanographi
san
diego
ca
usa
conceiv
design
experi
fp
perform
experi
fp
darsl
analyz
data
fp
darsl
spg
wrote
paper
fp
critic
review
manuscript
fp
darsl
spg
